Glucotrack secures $4M convertible note from leading shareholder for CBGM clinical trial

Glucotrack, Inc.

$4M secured convertible note from John Ballantyne at 8% interest, due in 12 months or upon sale event.
Note conversion requires stockholder approval; conversion at closing price or auto-convert if stock exceeds $5.
Three warrants issued: 2.13M shares at $1.875, 1.52M at $2.625, 1.19M at $3.375; exercisable after 12 months for 10 years.
Directors Shimon Rapp and Andrew Sycoff resigned July 29, no dispute.
Proceeds to fund first-in-human clinical trial of implantable continuous blood glucose monitor.

item 1.01 item 2.03 item 3.02 item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Shimon Rapp

Director

GCTK · Glucotrack, Inc.

Effective: 2024-07-29
Filed: July 31, 2024, 7:59 PM ET

On July 29, 2024, Shimon Rapp and Andrew Sycoff resigned from the board of directors.

Departed

Andrew Sycoff

Director

GCTK · Glucotrack, Inc.

Effective: 2024-07-29
Filed: July 31, 2024, 7:59 PM ET

On July 29, 2024, Shimon Rapp and Andrew Sycoff resigned from the board of directors.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Shimon Rapp resigned as Director at Glucotrack, Inc..

Action: resigned
Role: Director

Exact text from the filing

On July 29, 2024, Shimon Rapp and Andrew Sycoff resigned from the board of directors.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Andrew Sycoff resigned as Director at Glucotrack, Inc..

Action: resigned
Role: Director

Exact text from the filing

On July 29, 2024, Shimon Rapp and Andrew Sycoff resigned from the board of directors.

View on SEC.gov

Glucotrack, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-029775

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.